Loading...
Welcome to the Cimzia® Patient Support Portal

To register for access to the Cimzia® Patient Support Programme Portal,
please click here or contact TCP Homecare on Tel : 1800 810020.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; Email: medsafety@hpra.ie.